[1]唐 莉,李丹丹.大承气汤联合清热通腑灌肠方治疗急性胰腺炎疗效研究[J].陕西中医,2023,(3):333-336.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.014]
　TANG Li,LI Dandan.Efficacy study on Dachengqi decoction combined with Qingre Tongfu Guanchang decoction in treating acute pancreatitis[J].,2023,(3):333-336.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.014]
点击复制

大承气汤联合清热通腑灌肠方治疗急性胰腺炎疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年3期
页码:
333-336
栏目:
临床研究
出版日期:
2023-03-05

文章信息/Info

Title:
Efficacy study on Dachengqi decoction combined with Qingre Tongfu Guanchang decoction in treating acute pancreatitis
作者:
唐 莉; 李丹丹
(遂宁市中心医院中医及中西医结合科,四川 遂宁 629111)
Author(s):
TANG Li; LI Dandan
(Department of Traditional Chinese Medicine and Integrated Traditional Chinese and Western Medicine,Suining Central Hospital,Suining 629111,China)
关键词:
急性胰腺炎;  大承气汤;  清热通腑灌肠方;  奥曲肽;  血流动力学;  血淀粉酶
Keywords:
Acute pancreatitis;  Dachengqi decoction;  Qingre Tongfu Guanchang decoction;  Octreotide;  Hemodynamics;  Blood amylase
分类号:
R 657.5
DOI:
DOI:10.3969/j.issn.1000-7369.2023.03.014
文献标志码:
A
摘要:
目的:观察大承气汤联合清热通腑灌肠方治疗急性胰腺炎的临床疗效。方法:将96例已经确诊为急性胰腺炎的患者采用简单随机法分为对照组(n=48)和观察组(n=48)。对照组给予奥曲肽治疗,而观察组在奥曲肽基础上给予大承气汤口服联合清热通腑灌肠方保留灌肠治疗。比较两组胰腺体部血流指标、中医证候积分、Balthazar CT重症度指数分级及血淀粉酶的差异,统计两组临床疗效。结果:两组患者治疗前中医证候积分、Balthazar CT重症度指数分级比较,差异无统计学意义(均P>0.05)。两组中医证候总积分、主证和次证积分在治疗后均下降,且观察组中医证候总积分低于对照组,差异有统计学意义(均P<0.05)。治疗后观察组Balthazar CT重症度指数分级中Ⅰ级占比增加,Ⅲ级占比减少。治疗前,两组患者胰腺体部血流指标、血淀粉酶比较,差异无统计学意义(均P>0.05)。治疗后,两组胰腺体部血流量(BF)、血容量(BV)均高于治疗前,血淀粉酶及胰腺体部毛细血管表面通透性(PS)均低于治疗前,差异有统计学意义(均P<0.05)。治疗后,观察组胰腺体部BF、BV高于对照组,胰腺体部PS、血淀粉酶低于对照组,差异有统计学意义(均P<0.05)。观察组总有效率为91.67%(44/48)高于对照组的75.00%(36/48),差异有统计学意义(P<0.05)。结论:大承气汤联合清热通腑灌肠方治疗急性胰腺炎可有效减轻胰腺影像学改变,改善胰腺体部血流动力学,提高疗效。
Abstract:
Objective:To observe the clinical effect of Dachengqi decoction combined with Qingre Tongfu Guanchang decoction on acute pancreatitis.Methods:96 patients with acute pancreatitis were randomly divided into control group(n=48)and observation group(n=48).The control group were treated with octreotide,while the observation group were treated with Dachengqi decoction and Qingre Tongfu Guanchang decoction retention enema based on octreotide.Compared difference between the two groups in terms of pancreatic body blood flow index,TCM symptom score,Balthazar CT severity index grading and blood amylase,and to calculate curative effect of the two groups.Results:Before treatment,there were no difference in TCM symptom score and Balthazar CT severity index grading between the two groups,no statistically significant difference(all P>0.05).After treatment,total TCM symptom score and its main and secondary syndrome scores of the two groups decreased,and total TCM symptom score in the observation group were lower than those in the control group,difference statistically significant(all P<0.05).After treatment,the proportion of Balthazar CT severity index grade Ⅰ in the observation group increased and the proportion of grade Ⅲ decreased.Before treatment,there were no difference in blood flow index and blood amylase between the two groups(all P>0.05).After treatment,blood flow(BF)and blood volume(BV)of the two groups increased,and blood amylase and capillary surface permeability(PS)of the pancreatic body decreased,difference statistically significant(all P<0.05).After treatment,BF and BV of the pancreatic body in the observation group were higher than those in the control group,and the PS and blood amylase of the pancreatic body were lower than those in the control group,difference statistically significant(all P<0.05).The total effective rate in the observation group was 91.67%(44/48)higher than 75.00%(36/48)in the control group,difference statistically significant(P<0.05).Conclusion:Dachengqi decoction combined with Qingre Tongfu Guanchang decoction can effectively reduce the imaging changes of the pancreas,improve hemodynamics of the pancreas body and efficacy of acute pancreatitis.

参考文献/References:

[1] 刘丹希,孙 备.重症急性胰腺炎治疗的热点问题[J].临床外科杂志,2022,30(7):617-620.
[2] Vicente EV,Roberto CB,Cristina VB,et al.Acute pancreatitis in a patient treated with imatinib and gefitinib[J].Journal of Oncology Pharmacy Practice,2021,27(4):980-983.
[3] 李建洪,铁明慧,庞永诚,等.中医药综合治疗急性胰腺炎的研究进展[J].中国中医急症,2022,31(3):549-552.
[4] 郭迎雪,崔大鹏,聂双发,等.柴芩承气汤早期内服与灌肠联合高强度综合疗法治疗重症急性胰腺炎临床研究[J].陕西中医,2022,43(8):1041-1044.
[5] 中华中医药学会脾胃病分会.急性胰腺炎中医诊疗专家共识意见[J].中华中医药杂志,2017,32(9):4085-4088.
[6] 中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编委会,《中华消化杂志》编委会.中国急性胰腺炎诊治指南[J].临床肝胆病杂志,2019,35(12):2706-2711.
[7] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:124-151.
[8] 吴清明,彭铁立,王小虎.重症胰腺炎CT指数与预后的关系[J].中国医学影像技术,2001,17(12):1195-1196.
[9] Cardenas JK,Archibugi L,Poropat G,et al.Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis:A multicenter prospective cohort study[J].Digestive Endoscopy,2021,33(4):639-647.
[10] 姜 萌,赵 鹏.奥曲肽联合加贝酯治疗重症急性胰腺炎疗效及对患者血清细胞因子水平的影响[J].陕西医学杂志,2020,49(2):212-215.
[11] 吴珊珊,范铁兵.中医药治疗急性胰腺炎的临床应用进展[J].中国中医急症,2020,29(2):370-372.
[12] 袁铁超,陈国忠,王 婕,等.中医多途径治疗重症急性胰腺炎的研究进展[J].世界中医药,2020,15(16):2515-2518.
[13] 李君秋,肖铁刚,曹红燕,等.大承气汤治疗急性胰腺炎的临床疗效观察与分析[J].中华危重病急救医学,2022,34(1):91-94.
[14] 杨 丹,魏莉莉,孙银凤,等.中药灌肠联合西医常规疗法治疗重症急性胰腺炎临床疗效的Meta分析[J].中国中西医结合急救杂志,2022,29(2):177-182.
[15] 宋 洋,乐佳蕴,王小翠,等.大黄调节肠道菌群干预急性胰腺炎的研究进展[J].中国中医急症,2022,31(8):1307-1309.
[16] 刘敬莉,姚彦蓉,薛红梅,等.芒硝热敷袋的改良及在重症急性胰腺炎患者中的应用[J].中华急危重症护理杂志,2022,3(4):381-384.
[17] 张晓娟,赵良友,李建华,等.中药枳实的研究概况[J].中医药学报,2021,49(1):94-100.
[18] 荆文光,赵小亮,常 潞,等.基于血清药物化学和网络药理学的厚朴“下气除满”药效物质基础和作用机制研究[J].中国现代中药,2022,24(4):652-664.
[19] 赵 薇,郝谜谜,孙 璠,等.白花蛇舌草中环烯醚萜类成分的药理活性及其稳定性研究进展[J].天津中医药大学学报,2021,40(6):806-810.
[20] 孟 然,薛志忠,鲁雪林,等.蒲公英的功效成分与药理作用研究进展[J].江苏农业科学,2021,49(9):36-43.
[21] 陈 斯.延胡索化学成分和药理作用研究进展[J].中医药信息,2021,38(7):78-82.

相似文献/References:

[1]闫 风,连永红,姚成栋,等.大黄红藤消炎合剂治疗急性胰腺炎疗效及对患者淀粉酶、炎症因子影响*[J].陕西中医,2019,(6):729.
　YAN Feng,LIAN Yonghong,YAO Chengdong,et al.Effect of Dahuang Hongteng Xiaoyan mixture on acute pancreatitis amylase and inflammatory factors[J].,2019,(3):729.
[2]程相超.重症急性胰腺炎应用凉膈散联合乳果糖治疗对患者炎症反应的影响[J].陕西中医,2019,(7):879.
　CHENG Xiangchao..Influence for inflammatory reaction and microcirculation of severe acute pancreatitis in icu by Lianggesan and lactulose[J].,2019,(3):879.
[3]代晓玉,吴秋葶,姚佳琦,等.升降散治疗急性胰腺炎并发多器官功能障碍机制研究[J].陕西中医,2022,(5):550.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.002]
　DAI Xiaoyu,WU Qiuting,YAO Jiaqi,et al.The potential mechanisms of Shengjiang powder protect against multiple organ dysfunction in acute pancreatitis mice[J].,2022,(3):550.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.002]
[4]刘鸿雁,王 敏,古玉兰.柴芩承气汤保留灌肠治疗腑实热结型急性胰腺炎疗效及对患者中医症候积分、血清淀粉酶的影响[J].陕西中医,2022,(11):1551.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.014]
　LIU Hongyan,WANG Min,GU Yulan.Efficacy of Chaiqin Chengqi decoction retention enema in the treatment of acute pancreatitis of heat stagnation and Fu-organ excess type and its influence on scores of TCM syndromes and serum amylase[J].,2022,(3):1551.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.014]
[5]刘锟荣,卢 洁,秦百君,等.清解化攻汤对急性胰腺炎大鼠肠黏膜屏障和血清炎症因子的影响[J].陕西中医,2023,(2):149.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.003]
　LIU Kunrong,LU Jie,QIN Baijun,et al.Effects of Qingjie Huagong decoction on intestinal mucosal barrier and serum inflammatory factors in rats with acute pancreatitis[J].,2023,(3):149.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.003]
[6]尹 诗,谢安卫,肖敬鄂,等.二草清胰汤内服及保留灌肠联合乌司他丁治疗急性胰腺炎临床研究[J].陕西中医,2023,(2):183.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.010]
　YIN Shi,XIE Anwei,XIAO Jing'e,et al.Clinical study of oral administration and retention enema with Ercao Qingyi decoction combined with ulinastatin in the treatment of acute pancreatitis[J].,2023,(3):183.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.010]
[7]王 敏,罗小华,卢娟娟.通腑解毒方联合六合丹辅助西医治疗急性胰腺炎临床研究[J].陕西中医,2023,(4):471.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.014]
　WANG Min,LUO Xiaohua,LU Juanjuan.Clinical study of Tongfu Jiedu recipe combined with Liuhe Dan assisted western medicine in treating acute pancreatitis[J].,2023,(3):471.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.014]
[8]龙丹丹,姜 爽.清胆解毒汤合四逆散治疗急性胰腺炎肝胆湿热证临床研究[J].陕西中医,2024,(6):767.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.009]
　LONG Dandan,JIANG Shuang.Qingdan Jiedu decoction combined with Sini powder in the treatment of acute pancreatitis with liver and gallbladder damp-heat syndrome[J].,2024,(3):767.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.009]

备注/Memo

备注/Memo:
基金项目:四川省遂宁市卫生健康委员会中医药科研专项课题(SN2022B14)
更新日期/Last Update: 2023-03-13